-
Founded in:
2011-07-14 -
Country:
China -
Address:
Dunhua Economic Development Zone Industrial Park -
Tax NO.:
91222403578906132C -
Registered Funds:
37.68 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lincomycin hydrochloride |
It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, β-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as enterococci, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.
More
It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, β-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as enterococci, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria. |
859-18-7 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfamethoxazole |
It is a sulfonamide antibiotic. When used in combination with trimethoprim, it can double block bacterial folate metabolism and enhance the synergistic antibacterial effect, especially against Escherichia coli, Haemophilus influenzae, and Staphylococcus aureus.
More
It is a sulfonamide antibiotic. When used in combination with trimethoprim, it can double block bacterial folate metabolism and enhance the synergistic antibacterial effect, especially against Escherichia coli, Haemophilus influenzae, and Staphylococcus aureus. |
100mg | 723-46-6 | 33 |
| Trimethoprim |
It is a sulfonamide synergist that exerts its antibacterial effect by inhibiting dihydrofolate reductase. When used in combination with sulfamethoxazole, it can enhance the synergistic antibacterial effect and reduce drug-resistant strains.
More
It is a sulfonamide synergist that exerts its antibacterial effect by inhibiting dihydrofolate reductase. When used in combination with sulfamethoxazole, it can enhance the synergistic antibacterial effect and reduce drug-resistant strains. |
20mg | 738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Astragali Radix |
|
0 | ||
| SAPOSHNIKOVIAE RADIX |
|
0 | ||
| Atractylodes macrocephala (fried) |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CYNANCHI STAUNTONII RHIZOMA ET RADIX |
No description yet
More
No description yet |
0 | ||
| STEMONAE RADIX |
No description yet
More
No description yet |
0 | ||
| DL-Menthol |
No description yet
More
No description yet |
89-78-1 | 8 | |
| Platycodonis Radix |
No description yet
More
No description yet |
0 | ||
| Loquat leaves |
No description yet
More
No description yet |
0 | ||
| Mori Cortex |
No description yet
More
No description yet |
0 | ||
| PAPAVERIS PERICARPIUM |
No description yet
More
No description yet |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1,2,3,5/4,6-cyclohexane hexane nicotine ester |
This product is a mild peripheral vasodilator, which is gradually hydrolyzed into niacin and inositol in the body, so it has the pharmacological effects of both niacin and inositol, and has lipid-lowering effects. Its vasodilating effect is milder and more lasting than that of niacin, and it does not have side effects such as flushing and stomach discomfort after taking niacin. This product can selectively dilate blood vessels in lesions and sensitive areas stimulated by cold, while its dilating effect on normal blood vessels is weaker. In addition, it has the effects of dissolving blood clots, anticoagulation, anti-fatty liver, and reducing capillary fragility.
More
This product is a mild peripheral vasodilator, which is gradually hydrolyzed into niacin and inositol in the body, so it has the pharmacological effects of both niacin and inositol, and has lipid-lowering effects. Its vasodilating effect is milder and more lasting than that of niacin, and it does not have side effects such as flushing and stomach discomfort after taking niacin. This product can selectively dilate blood vessels in lesions and sensitive areas stimulated by cold, while its dilating effect on normal blood vessels is weaker. In addition, it has the effects of dissolving blood clots, anticoagulation, anti-fatty liver, and reducing capillary fragility. |
0 |